Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns

Photo of Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns
Facebook
VKontakte
share_fav

The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown.

view The New York Times: Latest News
#genetics and heredity
#23andme
#ovarian cancer
#tests medical
#dna deoxyribonucleic acid
#breast cancer
#promethease snpedia
#invitae corp